These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9650829

  • 1. Effect of lipo-prostaglandin E1 on crescentic-type anti-glomerular basement membrane nephritis in rats.
    Nagao T, Nagamatsu T, Suzuki Y.
    Eur J Pharmacol; 1998 May 01; 348(1):37-44. PubMed ID: 9650829
    [Abstract] [Full Text] [Related]

  • 2. Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats.
    Nagao T, Nagamatsu T, Suzuki Y.
    Eur J Pharmacol; 1996 Nov 28; 316(1):73-80. PubMed ID: 8982653
    [Abstract] [Full Text] [Related]

  • 3. Effect of DP-1904, a thromboxane A2 synthase inhibitor, administered from the autologous phase on crescentic-type anti-GBM nephritis in rats.
    Nagao T, Nagamatsu T, Suzuki Y.
    Jpn J Pharmacol; 1995 Jun 28; 68(2):137-44. PubMed ID: 7563970
    [Abstract] [Full Text] [Related]

  • 4. Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats.
    Nagao T, Ito M, Nagamatsu T, Suzuki Y.
    Eur J Pharmacol; 1994 Jul 11; 259(3):233-42. PubMed ID: 7982449
    [Abstract] [Full Text] [Related]

  • 5. [Studies on antinephritic effect of lipo PGE1 (1). Effect of lipo PGE1 on crescentic-type anti-GBM nephritis in rats].
    Nagao T, Hattori T, Ito M, Suzuki Y.
    Nihon Jinzo Gakkai Shi; 1991 Mar 11; 33(3):247-56. PubMed ID: 2062010
    [Abstract] [Full Text] [Related]

  • 6. [Studies on antinephritic effect of Lipo PGE1 (2). The suppressive action of Lipo PGE1 on the development of accelerated passive Heymann nephritis in rats].
    Nagao T, Ito M, Suzuki Y.
    Nihon Jinzo Gakkai Shi; 1991 Nov 11; 33(11):1071-9. PubMed ID: 1725534
    [Abstract] [Full Text] [Related]

  • 7. Effect of lipo-prostaglandin E1 on mesangial proliferative glomerulonephritis in rats.
    Luo C, Zhang X, Wang Y, Zhu Z, Deng A.
    J Huazhong Univ Sci Technolog Med Sci; 2005 Nov 11; 25(5):516-8. PubMed ID: 16463661
    [Abstract] [Full Text] [Related]

  • 8. Modulation of anti-glomerular basement membrane nephritis in rats by ONO-1301, a non-prostanoid prostaglandin I2 mimetic compound with inhibitory activity against thromboxane A2 synthase.
    Hayashi K, Nagamatsu T, Oka T, Suzuki Y.
    Jpn J Pharmacol; 1997 Jan 11; 73(1):73-82. PubMed ID: 9032136
    [Abstract] [Full Text] [Related]

  • 9. Studies on the antinephritic effect of plant components (4): Reduction of protein excretion by berberine and coptisine in rats with original-type anti-GBM nephritis.
    Hattori T, Furuta K, Nagao T, Nagamatsu T, Ito M, Suzuki Y.
    Jpn J Pharmacol; 1992 Jun 11; 59(2):159-69. PubMed ID: 1434112
    [Abstract] [Full Text] [Related]

  • 10. Antinephritic effect of Y-19018, a thromboxane A synthetase inhibitor, on crescentic-type anti-GBM nephritis in rats.
    Suzuki Y, Tsukushi Y, Ito M, Nagamatsu T.
    Jpn J Pharmacol; 1987 Oct 11; 45(2):177-85. PubMed ID: 3437587
    [Abstract] [Full Text] [Related]

  • 11. Antinephritic effect of prostaglandin E1 on serum sickness nephritis in rats. (3). Suppression of leukocytes by prostaglandin E1 as a mechanism for preventing immune complex glomerulonephritis.
    Nagamatsu T, Suzuki Y.
    Jpn J Pharmacol; 1986 Sep 11; 42(1):109-16. PubMed ID: 3795612
    [Abstract] [Full Text] [Related]

  • 12. Studies on antinephritic effect of mizoribine (p-INN, Bredinin), a new immunosuppressive agent, and azathioprine. (2) Effect on crescentic-type anti-GBM nephritis in rats.
    Okamoto K, Ito M, Suzuki Y.
    Jpn J Pharmacol; 1984 Jan 11; 34(1):33-41. PubMed ID: 6716716
    [Abstract] [Full Text] [Related]

  • 13. Suppression of experimental crescentic-type anti-glomerular basement membrane (GBM) nephritis by FK506 (tacrolimus hydrate) in rats.
    Hayashi K, Nagamatsu T, Ito M, Suzuki Y.
    Jpn J Pharmacol; 1996 Jan 11; 70(1):43-54. PubMed ID: 8822088
    [Abstract] [Full Text] [Related]

  • 14. Antinephritic effect of OKY-046, a thromboxane A synthetase inhibitor (1). Effects on crescentic-type anti-GBM nephritis in rats.
    Nagamatsu T, Tsukushi Y, Ito M, Kondo N, Suzuki Y.
    Jpn J Pharmacol; 1989 Apr 11; 49(4):501-9. PubMed ID: 2724689
    [Abstract] [Full Text] [Related]

  • 15. Studies on the antinephritic effects of plant components (6): antinephritic effects and mechanisms of phellodendrine (OB-5) on crescentic-type anti-GBM nephritis in rats (2).
    Hattori T, Furuta K, Hayashi K, Nagamatsu T, Ito M, Suzuki Y.
    Jpn J Pharmacol; 1992 Nov 11; 60(3):187-95. PubMed ID: 1491511
    [Abstract] [Full Text] [Related]

  • 16. Contribution of ED-1- and CD-8-positive cells to the development of crescentic-type anti-GBM nephritis in rats.
    Hattori T, Nagamatsu T, Ito M, Suzuki Y.
    Nihon Jinzo Gakkai Shi; 1994 Nov 11; 36(11):1228-39. PubMed ID: 7853754
    [Abstract] [Full Text] [Related]

  • 17. Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: possible role of TGF beta.
    Schneider A, Thaiss F, Rau HP, Wolf G, Zahner G, Jocks T, Helmchen U, Stahl RA.
    Kidney Int; 1996 Jul 11; 50(1):190-9. PubMed ID: 8807588
    [Abstract] [Full Text] [Related]

  • 18. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
    Lianos EA, Andres GA, Dunn MJ.
    J Clin Invest; 1983 Oct 11; 72(4):1439-48. PubMed ID: 6685136
    [Abstract] [Full Text] [Related]

  • 19. Studies on antinephritic effect of mizoribine (p-INN, Bredinin), a new immunosuppressive agent, and azathioprine (1) effect on the nephrotic type of anti-GBM nephritis in rats.
    Okamoto K, Ito M, Suzuki Y.
    Jpn J Pharmacol; 1983 Jun 11; 33(3):541-8. PubMed ID: 6620726
    [Abstract] [Full Text] [Related]

  • 20. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
    Liu D, Nazneen A, Taguchi T, Razzaque MS.
    Am J Nephrol; 2008 Jun 11; 28(4):555-68. PubMed ID: 18239382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.